NOVEL ORALLY ADMINISTERED DABIGATRAN FORMULATION

摘要

The invention relates to a new medicament formulation of the active substance dabigatran etexilate of formula I;;optionally in the form of the pharmaceutically acceptable salts thereof, as well as the preparation thereof.

主权项

1. Pharmaceutical composition for oral administration comprising a compound of formula I or a pharmaceutically acceptable salt or combinations thereof and as excipient at least one cyclodextrin agent.